Related Experiment Videos
Intracranial meningiomas following irradiation--a growing problem?
B S Musa1, I K Pople, B H Cummins
1Department of Neurosurgery, University Hospital of Wales, Health Park, Cardiff, UK.
British Journal of Neurosurgery
|January 1, 1995
Summary
High-dose radiation for brain tumors can lead to secondary meningiomas. These radiation-induced meningiomas show more malignant features and multiplicity compared to spontaneous ones.
Area of Science:
- Neuro-oncology
- Radiation oncology
- Pathology
Background:
- High-dose irradiation for intracranial tumors is a known risk factor for secondary neoplasms.
- Meningiomas are the most common primary tumors of the central nervous system, with a subset arising after radiation exposure.
Purpose of the Study:
- To investigate the clinical and pathological characteristics of meningiomas that develop after high-dose cranial irradiation.
- To compare radiation-induced meningiomas with spontaneous meningiomas and review existing literature on radiation-induced meningiomas.
Main Methods:
- Retrospective analysis of 10 cases of post-irradiation meningiomas.
- Comparison of clinical and pathological features with 262 spontaneous meningiomas from the same institution.
- Literature review of 69 previously reported radiation-induced meningiomas and 119 low-dose radiation-induced cases.
Main Results:
- Post-irradiation meningiomas represented 3.7% of all meningiomas treated.
- Malignant histological features and tumor multiplicity were significantly more common in radiation-induced meningiomas (p < 0.01).
- Increased long-term survival after radiotherapy may contribute to a rising incidence of post-irradiation meningiomas.
Conclusions:
- High-dose irradiation for brain tumors increases the risk of developing secondary meningiomas.
- Radiation-induced meningiomas exhibit distinct pathological characteristics, including higher rates of malignancy and multiplicity.
- Improved survival rates for primary brain tumors may lead to an increased occurrence of these secondary tumors.